Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCTR20200404005Phase 1Active, not recruiting
Phase 1 trial of permethrin in pediculosis capitis (2 arms), sponsored by Department of Community and Military Medicine. Primary endpoint: Reinfection rate of head louse infestation. Started Mar 2020; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on TCTR20200404005.